Bei Shan
Io Therapeutics (United States)(US)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Cholesterol and Lipid Metabolism, Cancer-related Molecular Pathways, Diabetes Treatment and Management, Peroxisome Proliferator-Activated Receptors
Most-Cited Works
- → Identification of a Nuclear Receptor for Bile Acids(1999)2,651 cited
- → Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ(2000)1,683 cited
- → Role of LXRs in control of lipogenesis(2000)1,658 cited
- → Accumulation of Dietary Cholesterol in Sitosterolemia Caused by Mutations in Adjacent ABC Transporters(2000)1,643 cited
- → The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL(2017)634 cited
- → Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR(2001)476 cited
- → A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates(2009)407 cited
- → Loss of Nuclear Receptor SHP Impairs but Does Not Eliminate Negative Feedback Regulation of Bile Acid Synthesis(2002)348 cited
- → CPF: An orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7α-hydroxylase gene(1999)281 cited
- → The Crystal Structure of PCSK9: A Regulator of Plasma LDL-Cholesterol(2007)239 cited